Specifically, unlike MTX alone, combination treatment induced a highly significant increase of CD45+ cells, NK cells, DCs, TAM1, monocytes, neutrophils and CD11b+ and CD103+ DC subsets compared to control mice in both tumor models (Fig. 5F-H and Supplementary Fig. S6G-I). Here, PTPRC is linked to neoplasm.